Merck

FDA weighs over-the-counter approval of Singulair

By MATTHEW PERRONE - Associated Press

Merck 1Q profit up 7 pct. despite sales decline

By The Associated Press - Associated Press

Endocyte surges on news for cancer drug

Associated Press

Merck Q4 net drops 14 pct. on generic competition

By LINDA A. JOHNSON - Associated Press

Merck, partners to jointly test hot cancer drug

By LINDA A. JOHNSON - Associated Press

Merck blood thinner gets ‘yes’ vote from FDA panel

By MATTHEW PERRONE - Associated Press

Merck recalls all supply of combo cholesterol drug

By LINDA A. JOHNSON - Associated Press

Stocks mostly lower after manufacturing slows down

By Steve Rothwell - Associated Press

CEO: Risks key for Merck to succeed, help patients

By LINDA A. JOHNSON - Associated Press

New Alzheimer’s drug studies offer patients hope

By LINDA A. JOHNSON - Associated Press

Merck ponders next step for troubled heart drug

By MARILYNN MARCHIONE - Associated Press

Merck ponders next step for troubled heart drug

By Marilynn Marchione - Associated Press

FDA panel backs Glaxo drug for rare sarcoma cancer

By MATTHEW PERRONE - Associated Press

FDA panel backs Glaxo drug for rare cancer

By MATTHEW PERRONE - Associated Press

Merck: FDA won’t OK its combo cholesterol drug now

By LINDA A. JOHNSON - Associated Press

Merck settles Mass. Medicaid fraud claims for $24M

By ASSOCIATED PRESS - Associated Press

FDA says Pfizer’s Prevnar vaccine works in adults

By MATTHEW PERRONE - Associated Press

Merck’s anti-clotting drug flops in key trial

By ASSOCIATED PRESS - Associated Press

FDA backs Vytorin for kidney disease patients

By ASSOCIATED PRESS - Associated Press

Boys should also get HPV vaccine, says medical panel

By Mike Stobbe - Associated Press

Listen Now

Threat Status podcast: What does Trump’s win mean for NATO, Ukraine and Russia?

Media must accept MAGA and stop condemning Christians, patriots

More than half of Christians are watching adult films, researchers say

Don’t believe the mainstream media: How FL, NE, SD stopped abortion ballot measures is a big deal

Latest Stories

FDA weighs over-the-counter approval of Singulair

Merck 1Q profit up 7 pct. despite sales decline

Endocyte surges on news for cancer drug

Merck Q4 net drops 14 pct. on generic competition

Merck, partners to jointly test hot cancer drug

Merck blood thinner gets ‘yes’ vote from FDA panel

Merck recalls all supply of combo cholesterol drug

Stocks mostly lower after manufacturing slows down

CEO: Risks key for Merck to succeed, help patients

New Alzheimer’s drug studies offer patients hope

Merck ponders next step for troubled heart drug

Merck ponders next step for troubled heart drug

FDA panel backs Glaxo drug for rare sarcoma cancer

FDA panel backs Glaxo drug for rare cancer

Merck: FDA won’t OK its combo cholesterol drug now

Merck settles Mass. Medicaid fraud claims for $24M

FDA says Pfizer’s Prevnar vaccine works in adults

Merck’s anti-clotting drug flops in key trial

FDA backs Vytorin for kidney disease patients

Boys should also get HPV vaccine, says medical panel